SAN DIEGO--(BUSINESS WIRE)--Splash Pharmaceuticals, Inc. (“Splash”), a closely held private biopharmaceutical company that develops novel cancer therapies, announced the presentation of an abstract ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results